Clinical Trial Update: Procarbazine in Treating Patients With Recurrent Brain Tumor [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on procarbazine for recurrent brain tumors (Phase 1/Phase 2). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor

Drugs mentioned

• Procarbazine (procarbazine)

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED